Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission.
Interleukin-1β and Interleukin-1 Receptor Antagonist Appear in Grey Matter Additionally to White Matter Lesions during Experimental Multiple Sclerosis.
Frequency of Blood-tissue Parasitic Infections in Patients with Multiple Sclerosis, as Compared to their Family Members.
Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectives.
The Nuclear IκB Family Protein IκBNS Influences the Susceptibility to Experimental Autoimmune Encephalomyelitis in a Murine Model.
The influence of immunomodulatory treatment on the clinical course of multiple sclerosis.
Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis.
A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada.
Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination.
Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis.
Pycnogenol Attenuates the Release of Proinflammatory Cytokines and Expression of Perilipin 2 in Lipopolysaccharide-Stimulated Microglia in Part via Inhibition of NF-κB and AP-1 Activation.
The gut-brain axis: interactions between Helicobacter pylori and enteric and central nervous systems.
Unveiling the anti-inflammatory activity of Sutherlandia frutescens using murine macrophages.
Hereditary diffuse leukoencephalopathy with spheroids - a volumetric and radiological comparison with multiple sclerosis patients and healthy controls.
Epidemiology of multiple sclerosis in Qom: Demographic study in Iran.
Multiple perspectives on the health service need, use, and variability among older adults with multiple sclerosis.
Clinical Manifestations and Spinal Cord Magnetic Resonance Imaging Findings in Chinese Neuromyelitis Optica Patients.
Statin treatment 0061ffects cytokine release and phagocytic activity in primary cultured microglia through two separable mechanisms.
A pilot study of an exercise-based patient education program in people with multiple sclerosis.
Brain Perfusion and Vasoreactivity in Multiple Sclerosis.
Focal MMP-2 and MMP-9 Activity at the Blood-Brain Barrier Promotes Chemokine-Induced Leukocyte Migration.
Exercise as a therapy for improvement of walking ability in adults with multiple sclerosis: A meta-analysis.
Metabolic and Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs.
RAD001 (everolimus) attenuates experimental autoimmune neuritis by inhibiting the mTOR pathway, elevating Akt activity and polarizing M2 macrophages.
Association of TIM-1 5383-5397ins/del and TIM-3 -1541C>T polymorphisms with multiple sclerosis in Isfahan population.
Pages
« first
‹ previous
…
601
602
603
604
605
606
607
608
609
…
next ›
last »